See more.
Know more.
We are LUMICKS, a life science company aiming to transform the world of immuno-oncology and molecular biology.
Cell Avidity
Revolutionize binding for the future of cell & antibody therapeutics
Imagine measuring the combined strength of cell-cell / cell-protein binding, generating direct, physiologically relevant measurements of binding in its full, dynamic complexity. To support progress in immunotherapy, we need to measure binding the way it happens—in real life, in real cells. This is Cell Avidity.
Dynamic Single-Molecule
Revealing biomolecular insights never before available
What if you could measure molecular properties and interactions while simultaneously revealing the processes in real-time? A technology that unravels the crucial and dynamic interactions taking place at the molecular level and gives you direct proof of the mechanisms involved. Our Dynamic Single-Molecule technology provides you with all of that, enabling the understanding of the root of disease development at the molecular level and accelerate therapeutic breakthroughs.
Our mission
We empower the academic and pharmaceutical communities with cutting-edge technologies to deeply understand the mechanisms of life and disease, driving the discovery and development of life-saving therapies.
Button Text
SMBio 2026 UK & Ireland
Symposium
May 20, 2026
01-01-20
This is some text inside of a div block.
Single Molecule Visualisation of Human Topoisomerase 2A Decatenation Reveals Substrate Requirements
Webinar
December 3, 2025
01-01-20
This is some text inside of a div block.
Improving the anti-tumor efficacy of CAR-T through biomolecular condensation (中文)
Webinar
December 1, 2025
01-01-20
This is some text inside of a div block.
Cell Avidity Uncovers Novel KIR:HLA binding predicting patient survival post stem cell transplant
Webinar
November 19, 2025
01-01-20
This is some text inside of a div block.
No items found.